Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shayan Falasiri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Urology Case Reports|July 17, 2023
Retroperitoneal drop metastases following robotic partial nephrectomy for renal cell carcinomaKareem Elgendi, David Nelwan, Richard Barry Sirard, et al.
Journal of Clinical Medicine|October 21, 2020
The Immune Microenvironment in Penile Cancer and Rationale for ImmunotherapyMohamed E Ahmed, Shayan Falasiri, Ali Hajiran, et al.
Gene|May 21, 2018
Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival ratesShayan Falasiri, Tasnif Rahman, Yaping N Tu, et al.
The Journal of Sexual Medicine|November 23, 2025
Lateral thinking: the Carrion modified mini-jupette slingHannah H Guan, Raul Fernandez-Crespo, Shayan Falasiri, et al.
International Journal of Cardiology|August 13, 2016
When should fractional flow reserve be performed to assess the significance of borderline coronary artery lesions: Derivation of a simplified scoring systemFadi A Matar, Shayan Falasiri, Charles B Glover, et al.
Cellular & Molecular Immunology|November 16, 2019
Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival ratesJuan F Arturo, Boris I Chobrutskiy, Michelle Yeagley, et al.
International Journal of Immunogenetics|July 23, 2021
A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanomaDhruv N Patel, Michelle Yeagley, Juan F Arturo, et al.
Oncogene|November 20, 2019
Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade gliomaBoris I Chobrutskiy, Michelle Yeagley, Price Tipping, et al.
Pediatric Hematology and Oncology|February 22, 2021
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for SarcomasMichelle Yeagley, Boris I Chobrutskiy, Etienne C Gozlan, et al.
Molecular Immunology|August 20, 2022
Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivityRachel A Eakins, Andrea Chobrutskiy, Jamie K Teer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Urology Case Reports|July 17, 2023
Retroperitoneal drop metastases following robotic partial nephrectomy for renal cell carcinomaKareem Elgendi, David Nelwan, Richard Barry Sirard, et al.
Journal of Clinical Medicine|October 21, 2020
The Immune Microenvironment in Penile Cancer and Rationale for ImmunotherapyMohamed E Ahmed, Shayan Falasiri, Ali Hajiran, et al.
Gene|May 21, 2018
Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival ratesShayan Falasiri, Tasnif Rahman, Yaping N Tu, et al.
The Journal of Sexual Medicine|November 23, 2025
Lateral thinking: the Carrion modified mini-jupette slingHannah H Guan, Raul Fernandez-Crespo, Shayan Falasiri, et al.
International Journal of Cardiology|August 13, 2016
When should fractional flow reserve be performed to assess the significance of borderline coronary artery lesions: Derivation of a simplified scoring systemFadi A Matar, Shayan Falasiri, Charles B Glover, et al.
Cellular & Molecular Immunology|November 16, 2019
Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival ratesJuan F Arturo, Boris I Chobrutskiy, Michelle Yeagley, et al.
International Journal of Immunogenetics|July 23, 2021
A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanomaDhruv N Patel, Michelle Yeagley, Juan F Arturo, et al.
Oncogene|November 20, 2019
Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade gliomaBoris I Chobrutskiy, Michelle Yeagley, Price Tipping, et al.
Pediatric Hematology and Oncology|February 22, 2021
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for SarcomasMichelle Yeagley, Boris I Chobrutskiy, Etienne C Gozlan, et al.
Molecular Immunology|August 20, 2022
Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivityRachel A Eakins, Andrea Chobrutskiy, Jamie K Teer, et al.
Pageof 1